期刊文献+

耐碳青霉烯类鲍曼不动杆菌OXA基因检测及同源性分析 被引量:11

Study on oxacillinase encoding gene and homology of carbapenem-resistant Acinetobacter baumannii
原文传递
导出
摘要 目的了解台州地区碳青霉烯类耐药鲍曼不动杆菌的耐药性、碳青霉烯酶基因型以及同源性。方法 63株碳青霉烯类耐药鲍曼不动杆菌经VITEK 2 Compact进行细菌鉴定及药敏分析,用K-B法复核药敏结果,采用多重PCR扩增分析碳青霉烯酶的基因型;采用脉冲场凝胶电泳(pulsed field gel electrophoresis,PFGE)分析其同源性。结果 63株菌株为多重耐药菌株,除多粘菌素、阿米卡星、头孢哌酮/舒巴坦外,对其他常用抗生素的耐药率均在70%以上。63株菌株检测出OXA-51基因60株(95.2%),OXA-23基因58株(92.1%),两个基因同时存在的有58株(92.1%)。PFGE结果显示碳青霉烯类鲍曼不动杆菌主要分为5个克隆型,其中A、B两个为主型。结论产OXA酶是台州地区耐碳青霉烯类鲍曼不动杆菌的主要耐药机制之一,其中OXA-23是主要的基因型。 Objective To analyze the drug resistance and genotypes of carbapenem-resistant Acinetobacter baumannii and their ho- mology in Taizhou. Methods 63 Acinetobacter baumannii strains were identified and their drug susceptibility were detected by using VITEK 2 Compact. The results of drug susceptibihty test were rechecked by Kribry-Bauer methods. The genes of carbapenemase were am- plified by multiplex polymerase chain reaction. Homology of the resistant isolates was analyzed by PFGE. Results The 63 strains were multi-resistant. The resistant rates to common antimicrobial agents exceeded 70% except to polymyxin, amikacin, and cefoperazone/sul- bactam. Among the 63 strains, 60 isolates (95.2%) carried OXA-51 gene, 58 isolates (92.1%) carried OXA-23 gene, and 58 strains (92.1% ) possessed both the two genes. PFGE showed that Acinetobacter baumannii can be divided into 5 different genotypes, with type A and type B playing a dominant role in epidemiology. Conclusion The production of OXA carbapenemase in Acinetobacter baumannii was one of the main mechanisms of carbapenem-resistance in our hospital. OXA-23 is the major carbapenemase gene.
机构地区 台州医院检验科
出处 《中国微生态学杂志》 CAS CSCD 2013年第3期332-334,共3页 Chinese Journal of Microecology
关键词 鲍曼不动杆菌 耐药性 碳青霉烯酶 OXA基因 Acinetobacter baumannii Drug-resistance Carbapenemase OXA gene
  • 相关文献

参考文献8

  • 1JENNIFER M, ADAMS H, EZENWA O, et al. Molecular epidemiology of carbapenem-nonsusceptiblc Acinetobacter baumannii in the United States[ J]. Clin Microbiol,2011,49( 11 ) :3849-3854.
  • 2WANG H,GUO P,SUN H, et al. Molecular epidemiology of clinical i- solates of carbapenem-resistant Acinetobaeter spp. from Chinese hospi- tals[ J]. Antimicrob Agents Chemother,2007,51 (11) :4022-4028.
  • 3TENOVER F C, ARBEIT R O, GOERING R V,et al. Interpreting chn)- mosomal DNA restriction patterns produced by pulsed field gel electro- phoresis : criteria for bacterial strain typing [ J ]. J Clin Microbiol, 1995, 33 (9) :2233-2239.
  • 4HIGG1NS P G, DAMMHAYN C, HACKEL M, et al. Global spread of carbapenem-resistant Acinetobacter baumannii [ J ]. J Antimicrob Che- mother,2010,65 (2) :233-238.
  • 5石岩,刘大为,许大波,徐英春,陈民均,王辉.泛耐药鲍曼不动杆菌感染临床治疗初探[J].中国感染与化疗杂志,2007,7(1):34-37. 被引量:112
  • 6李春,王中新,沈继录.鲍曼不动杆菌对碳青霉烯类耐药机制研究进展[J].国外医药(抗生素分册),2009,30(2):54-58. 被引量:28
  • 7周铁丽,李响新,王忠永,包其郁,吴庆,陈慧.鲍曼不动杆菌OXA-51样碳青霉烯酶基因分型与耐药性研究[J].中华检验医学杂志,2008,31(7):812-816. 被引量:15
  • 8HE C,XIE Y,ZHANG L, et al. Increasing imipenem resistance and dissemination of the 1SAbal-associated blaOXA-23 gene among Acineto- bacter baumannii isolates in an intensive care unit[ J]. J Med Microbi- o1,2011,60( 3 ) :537-341.

二级参考文献47

共引文献152

同被引文献88

  • 1余素飞,厉世笑,黄林瑶,彭敏飞,许春燕,朱小丽.碳青霉烯类耐药鲍曼不动杆菌的耐药性及碳青霉烯酶基因型研究[J].中华临床感染病杂志,2013,6(2):108-110. 被引量:6
  • 2龙军,周韶松,彭永正,林裕锋.肺炎克雷伯菌随机扩增多态性DNA的分子流行病学研究[J].热带医学杂志,2007,7(4):330-331. 被引量:6
  • 3Lee K, Chong Y, Shin HB. Modified Hodge and EDTA-disk syner- gy tests to screen metallo-beta-lactamase-producing strains of Pseud- omonas and Acinetobacter species [ J]. Clin Microbiol & Infect, 2001, 7(2): 88-91.
  • 4Donald HM, Scalfe W, Amyes SG, et al. Sequence analysis of ARI-1, a novel OXA β-1actamase, responsible for imipenem resist- ance in Acinetobacter baumanii[ J]. Antimicrob Agents Chemother,2000, 44(1) : 196-199.
  • 5Bou G, Oliver A. OXA-24, a novel class D [3-1actamase with car- bapenemase activity in an Acinetobacter baumannii clinical strain [J]. Antimicrob Agents Chemother, 2000, 44(6) : 1556-1561.
  • 6Tysall L, Stockdale MW, Chadwick PR, et al. IMP-1 carbapene- mase detected in all Acinetobacter clinical isolate from the UK [ J ]. Antimicrob Chemother, 2002, 49( 1 ) : 217-218.
  • 7Tsakris A, Poumaras S, Woodford N, et al. Outbreak of infectious caused by Pseudomonas aeruginosa producing -VIM-1 carbapenemase in Greece[J]. Clin Microbiol, 2000, 38(3) : 1290-1292.
  • 8Poirel L, Nordmarm P. Carhapenem resistance in Aci:to6aeter 6au- mannii: mechanisms and epidemiology [ J ]. Clin Microbiol Infect, 2006, 12(9): 826-836.
  • 9Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological and epidemiological study[J]. Lancet Infect Dis, 2010, 10(9) : 597-602.
  • 10Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta lactamase gene, blaNDM.1 , and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India [ J ]. Antimicrob Agents Chemother, 2009, 53(12): 5046-5054.

引证文献11

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部